Reference value of serum pregnancy associated plasma protein-A (PAPP-A) in 1st trimester of pregnancy as an antenatal screening tool for genetic disorders
DOI:
https://doi.org/10.55629/pakjpathol.v35i4.808Abstract
Objective: Our study aims to establish the normal reference value of Serum Pregnancy Associated Plasma Protein-A (PAPP-A) in 1st trimester of pregnancy as an antenatal screening tool for genetic disorders
Material and Methods: This cross-sectional study was conducted in Chughtai Institute of Pathology, from November 2022 to April 2023. One hundred and twenty samples of healthy pregnant females between 18 – 40 years were collected by purposive, non-probability technique as per inclusion and exclusion criteria. Analysis of samples was done for quantitative measurement of serum PAPP-A levels. Statistical Analysis was done using SPSS version 21. For normality check, Kolmogorov-Smirnov test was applied with < 0.05 P value considered as significant. 2.5th and 97.5th percentiles were computed using the formula 0.025 (n+1) and 0.975 (n+1) respectively.
Results: Mean age of all pregnant female (n=120) subjects was 25.90 ± 4.70 years. Serum PAPP-A was measured and mean PAPP-A level for n=120 samples was 3539 mIU/L ± 2830 with median level of 2405 mIU/L. We established the reference value in our population by Rank-based non-parametric method on the basis of 2.5th and 97.5th percentiles as 436 mIU/L - 10000 mIU/L.
Conclusion: To our knowledge this is the first study to establish 1st trimester (10th to 14th week) reference value of serum PAPP-A in our population. Furthermore, our study will provide a reference for future study on establishing multiple of Median (MoM) of our population and starting an antenatal screening program by providing patient specific risk of genetic disorders.
Keywords: Pregnancy Associated Plasma Protein-A, Antenatal screening, Reference value.
References
Conover CA, Oxvig C. The pregnancy-associated plasma protein-A (PAPP-A) story. 2023; 44(6): 1012-28. DOI: https://doi.org/10.1210/endrev/bnad017
Zhong Q, Chu H, Wang G, Zhang C, Li R, Guo F, et al. Structural insights into the covalent regulation of PAPP-A activity by proMBP and STC2. Cell Discov. 2022; 8(1): 137. DOI: https://doi.org/10.1038/s41421-022-00502-2
Buhimschi IA, Zhao G, El Helou Y, Frye LJ, Winikoff B, Raymond EGJTJoALM. Analytical comparison of pregnancy-associated plasma protein-a (PAPP-A) immunoassays for biochemical determination of gestational age. J Appl Lab Med. 2021; 6(6): 1517-32. DOI: https://doi.org/10.1093/jalm/jfab057
Livrinova V, Petrov I, Samardziski I, Jovanovska V, Boshku AA, Todorovska I, et al. Clinical importance of low level of PAPP-A in first trimester of pregnancy-an obstetrical dilemma in chromosomally normal fetus. Open Access Maced J Med Sci . 2019; 7(9): 1475-9. DOI: https://doi.org/10.3889/oamjms.2019.384
Peris M, Reid SM, Dobie S, Bonacquisto L, Shepherd DA, Amor DJJDM, et al. First‐trimester maternal serum biomarkers and the risk of cerebral palsy. Dev Med Child Neurol. 2021;63(2):183-9. DOI: https://doi.org/10.1111/dmcn.14732
Rose NC, Kaimal AJ, Dugoff L, Norton ME, Obstetricians ACo, Obstetrics GJ, et al. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstet Gynecol. 2020 Oct;136(4):e48-e69. DOI:https://doi.org/10.1097/aog.0000000000004084
Khanam Z, Mittal P, Suri JJTJoO, India Go. Does the addition of serum PAPP-A and β-hCG improve the predictive value of uterine artery pulsatility index for preeclampsia at 11–14 weeks of gestation? A prospective observational study. 2021: 1-9.
Khanam Z, Mittal P, Suri J. Does the addition of serum papp-a and β-hcg improve the predictive value of uterine artery pulsatility index for preeclampsia at 11-14 weeks of gestation? A prospective observational study. J Obstet Gynaecol India. 2021; 71(3): 226-34. DOI: https://doi.org/10.1007/s13224-020-01420-7
Kitchen FL, Jack BW. Prenatal screening. StatPearls [Internet]: StatPearls Publishing; 2022.
Katar MJIJMB. Estimation of median second trimester screening test values at a single hospital. 2020; 3(1): 29-37.
DOI: https://dx.doi.org/10.14744/ijmb.2019.22932
Antsaklis P, Fasoulakis Z, Theodora M, Diakosavvas M, Kontomanolis EN, Kontomanolis EJC. Association of low maternal pregnancy-associated plasma protein A with adverse perinatal outcome. Cureus. 2019;11(6): e4912. DOI: https://doi.org/10.7759/cureus.4912
Kilercik M, Yozgat I, Serdar MA, Aksungar F, Göğüş S, Solak S, et al. What are the predominant parameters for Down syndrome risk estimation in first-trimester screening: A data mining study. Turkish J Biochem. 2022;47(6):704-9. DOI: https://doi.org/10.1515/tjb-2022-0004
Rifai N. Tietz textbook of clinical chemistry and molecular diagnostics-e-book: 6th Ed, Elsevier Health Sciences; 2017.
Ozarda Y. Reference intervals: Current status, recent developments and future considerations. 2016; 26(1): 5-16. DOI: https://doi.org/10.11613/bm.2016.001
Bibi A, Haroon ZH, Shujaat A, Aamir M, Irum S, Jaffar SR. Establishing biotinidase reference interval: A foundation stone for newborn screening of biotinidase deficiency in Pakistan. J Pak Med Assoc. 2022; 72(1): 97-100. DOI: https://doi.org/10.47391/jpma.2167
Henny J, Vassault A, Boursier G, Vukasovic I, Brguljan PM, Lohmander M, et al. Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med. 2016; 54(12): 1893-900. DOI: https://doi.org/10.1515/cclm-2016-0793
Ozarda Y, Sikaris K, Streichert T, Macri J. IFCC Committee on Reference intervals and Decision Limits (C-RIDL). Distinguishing reference intervals and clinical decision limits–A review by the IFCC Committee on Reference Intervals and Decision Limits. Crit Rev Clin Lab Sci. 2018 Sep;55(6):420-31. DOI:https://doi.org/10.1080/10408363.2018.1482256
Horowitz G, RD jones G, Establishment and use of reference intervals: clinical chemistry and immunology. 1st South Asia Edition. New Dehli: Elsevier; 2018: p183-4
Afaaq A, Khan MD, Batool H, Chughtai O, Chughtai AS, Ashraf SJPJoP. Reference interval of placental growth factor in non-pregnant and pregnant females. 2023; 34(4): 102-8. DOI: https://doi.org/10.55629/pakjpathol.v34i4.772
Ozarda Y, Higgins V, Adeli KJCC, Medicine L. Verification of reference intervals in routine clinical laboratories: practical challenges and recommendations. Clin Chem Lab Med. 2018; 57(1): 30-7. DOI: https://doi.org/10.1515/cclm-2018-0059
Saletra-Bielińska A, Kosińska-Kaczyńska K, Szymusik I, Kaczyński B, Brawura-Biskupski-Samaha R, Kozłowski S, et al. Both low and high PAPP-A concentrations in the first trimester of pregnancy are associated with increased risk of delivery before 32 weeks in twin gestation. J Clin Med. 2020; 9(7): 2099. DOI: https://doi.org/10.3390/jcm9072099
Turner JM, Kumar SJJoCM. Low first trimester pregnancy-associated plasma protein-A levels are not associated with an increased risk of intrapartum fetal compromise or adverse neonatal outcomes: a retrospective cohort study. J Clin Med. 2020; 9(4):1108. DOI: https://doi.org/10.3390/jcm9041108
Kanwal S, Asif N, Baqai S, Ijaz A, Bahadur K, Nida S. Determination of medians of biochemical serum markers in first trimester of healthy pregnant women in tertiary care setup. Pak Armed Forces Med J. 2022;72(2):668-71. DOI: https://doi.org/10.51253/pafmj.v72i2.2996
Ramezani S, Doulabi MA, Saqhafi H, Alipoor M. Prediction of gestational diabetes by measuring the levels of pregnancy associated plasma protein-A (PAPP-A) during gestation weeks 11–14. J Reprod Inferti. 2020; 21(2): 130.
Shiefa S, Amargandhi M, Bhupendra J, Moulali S, Kristine T. First trimester maternal serum screening using biochemical markers PAPP-A and free β-hCG for down syndrome, patau syndrome and edward syndrome. Indian J Clin Biochem. 2013; 28(1): 3-12. DOI: https://doi.org/10.1007/s12291-012-0269-9
Hasegawa J, Wada S, Kasamatsu A, Nakamura M, Hamanoue H, Iwata E, et al. Distribution of PAPP-A and total hCG between 11 and 13 weeks of gestation in Japanese pregnant women. J Maternal-Fetal Neonatal Med. 2020; 33(12): 2017-22. DOI:https://doi.org/10.1080/14767058.2018.1536737
Katar M. Determination of median values of first trimester screening tests: A Tokat scale retrospective study. Van Sag Bil Derg. 2019; 12(2): 15-21.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Dr Muhammad Masood Afzal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
